Evidence map›Paper›PMID 41858345›Full record

ArticleFrontiers in oncology2026

A foundation model-based multi-instance learning framework for accurate prediction of lymph node metastasis in prostate cancer from whole slide images.

Guang Zeng, Weiwei Li, Haonan Mei, Ran Du

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Guang ZengDivision of Urology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, Hubei, China.
Weiwei LiDivision of Nephrology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, Hubei, China.
Haonan MeiThe First Clinical College, Wuhan University, Wuhan, Hubei, China.
Ran DuDivision of Nephrology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, Hubei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Nodal involvement (N stage) is a key prognostic factor in prostate cancer (PCa). Conventional imaging and histopathology often have limited sensitivity and inter-observer variability. AI-based computational pathology, using multi-instance learning (MIL) and foundation models, offers a promising approach for accurate and interpretable N stage prediction from H&E-stained whole slide images (WSIs). Methods: In this multicenter retrospective study, we developed a weakly supervised deep learning framework integrating MIL with domain-adapted foundation model encoders (UNI-v2, CONCH, ResNet-50) to predict N stage. WSIs from 280 RHWU patients were used for training and 306 TCGA patients for external validation. Attention heatmaps enabled interpretability, while transcriptomic analyses explored molecular correlates via differential expression and bioinformation analysis. Results: The UNI-v2-based model achieved the highest performance (AUC 0.879 in RHWU, 0.850 in TCGA), surpassing CONCH and ResNet-50. Attention heatmaps highlighted tumor-stromal interfaces and poorly differentiated tumor clusters. Transcriptomic analysis identified 94 differentially expressed genes; upregulated genes were enriched in cell cycle, and immune pathways, while downregulated genes involved ion transport and metabolism. Conclusions: This AI-MIL framework accurately predicts nodal involvement in PCa and provides biologically interpretable insights, supporting its potential as a precision oncology tool for risk stratification and treatment planning.

Indexed as

artificial intelligencecomputational pathologylymph node metastasismulti-instance learningN stagingprostate cancer

Identifiers

PMID41858345
PMCPMC12995785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.